Monte Rosa Therapeutics, Inc.
GLUE • NASDAQ
Monte Rosa Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Markus Warmuth, with a market cap of $1.4B.
Market Cap$1.4B
Employees109.0
CEOMarkus Warmuth
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Monte Rosa Therapeutics, Inc. FAQ
Common questions about Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $16.8M.
Monte Rosa Therapeutics, Inc. has approximately 109 employees.